References
- F. Ahmed, V. Vyas, S. Goodin, T. S. Ravikumar, E. H. Rubin and E. Gupta, In vitro activation of Irinotecan to SN-38 by human liver and intestine, Anticancer Res. 19 (1999) 2067--2071.
- C. H. Takimoto and S. G. Arbuck, Topoisomerase I Targeting Agents: The Camptothecins, in Cancer Chemotherapy and Biotherapy: Principles and Practice (Eds. B. A. Chabner and D. L. Longo), 33rd ed. Lippincott Williams & Wilkins, Philadelphia 2001, pp. 579--646.
- R. M. Wadkins, P. M. Potter, B. Vladu, J. Marty, G. Mangold, S. Weitman, G. Manikumar, M. C. Wani, M. E. Wall and D. D. Von Hoff, Water soluble 20(S)-glycinate ester of 10,11-methylenedioxycamptothecins are highly active against human breast cancer xenografts, Cancer Res. 59 (1999) 3424--3428.
- S. Anabousi, M. Laue, C. M. Lehr, U. Bakowsky and C. Ehrhardt, Assessing transferrin modification of liposomes by atomic force microscopy and transmission electron microscopy, Eur. J. Pharm. Biopharm. 60 (2005) 295--303; DOI: 10.1016/j.ejpb.2004.12.009.10.1016/j.ejpb.2004.12.009
- S. A. Abraham, D. N. Waterhouse, L. D. Mayer, P. R. Cullis, T. D. Madden and M. B. Bally, The liposomal formulation of doxorubicin, Methods Enzymol. 391 (2005) 71--97; DOI: 10.1016/S0076-6879(05)91004-5.10.1016/S0076-6879(05)91004-5
- S. P. Vyas, S. Quraishi, S. Gupta and K. S. Jaganathan, Aerosolized liposome-based delivery of amphotericin B to alveolar macrophages, Int. J. Pharm. 296 (2005) 2--25; DOI: 10.1016/j.ijpharm.2005.02.003.10.1016/j.ijpharm.2005.02.003
- H. Iinuma, K. Maruyama, K. Okinaga, K. Sasaki, T. Sekine, O. Ishida, N. Ogiwara, K. Johkura and Y. Yonemura, Intracellular targeting therapy of cisplatin-encapsulated transferring-polyethyl-eneglycol liposome on peritoneal dissemination of gastric cancer, Int. J. Cancer 99 (2002) 130--137; DOI: 10.1002/ijc.10242.10.1002/ijc.10242
- R. J. Hong and Y. L. Tseng, Phase I and pharmacokinetic study of a stable, polyethylene-glycolated liposomal doxorubicin in partients with solid tumors, Cancer 91 (2001) 1826--1833; DOI: 10.1002/1097-0142(20010501)91:9:1826::AID-CNR1203>3.0.CO,2-J.
- N. Oku, K. Doi, Y. Namba and S. Okada, Therapeutic effect of adriamycin encapsulated in long-circulating liposomes on Meth-A-sarcoma-bearing mice, Int. J. Cancer 58 (1994) 415--419; DOI: 10.1002/ijc.2910580318.10.1002/ijc.2910580318
- Y. Tokudome, N. Oku, K. Doi, Y. Namba and S. Okada, Antitumor activity of vincristin encapsulated in glucuronide-modified long-circulating liposomes in mice bearing Meth A sarcoma, Biochim. Biophys. Acta 1279 (1996) 70--74; DOI: 10.1016/005-2736(95)00242-1.
- G. L. Berestein, L. Kasi, M. G. Rosemblum, T. Haynie M. Jahns, H. Glenn, R. Mehta, G. M. Mavlight and E. M. Hersh, Clinical pharmacology of 99mTc-labeled liposomes in patients with cancer, Cancer Res. 44 (1984) 375--378.
- K. Shimada, A. Miyagishima, Y. Sadzuka, Y. Nozawa and S. Hirota, Determination of the thickness of fixed aqueous layer around the polyethleneglycol-coated liposomes, J. Drug Target. 3 (1995) 283--289.
- T. Yuda, Y. Pongpaibul, K. Maruyama and M. Iwatatsuru, Prolongation of liposome circulation time by various derivatives of polyethyleneglycols, Bio. Pharm. Bull. 19 (1996) 1347--1351.
- V. P. Torchilin, V. G. Omelyanenko, M. I. Papisov, A. A. Bogdanov, V. S. Trubetsloy, J. N. Herron and C. A. Gentry, Poly(ethylene glycol) on the liposome surface: on the mechanism of polymercoated liposome longevity, Biochem. Biophys. Acta 1195 (1994) 11--20; DOI: 10.1016/005-2736(94) 90003-5.
- J. Janzen, X. Song and D. E. Brooks, Interfacial thickness of liposomes containing poly(ethylene glycol)-cholesterol from electrophoresis, Biophys. J. 70 (1996) 313--320; DOI: 10.1016/S0006-3495 (96)79572-3.
- A. A. Gabizon, H. Shameeda and S. Zalpisky, Pros and cons of the liposome platform in cancer drug targeting, J. Liposome Res. 16 (2006) 175--183; DOI: 10.1080/08982100600848769.10.1080/08982100600848769
- Y. Sadzuka, H. Takabe and T. Sonobe, Liposomalization of SN-38 as active metabolite of CPT-11, J. Control. Rel. 108 (2005) 453--459; DOI: 10.1016/j.jconrel.2005.08.023.10.1016/j.jconrel.2005.08.023
- A. L. Klibanov, K. Maruyama, V. P. Torchilin and L. Huang, Amphipatic polyethyleneglycols effectively prolong the circulation time of liposomes, FEBS. J. 268 (1990) 235--237; DOI: 10.1016/0014-5793(90)81016-H.10.1016/0014-5793(90)81016-H
- T. Xuana, J. A. Zhang and I. Ahmad, HPLC method for determination of SN-38 content and SN-38 entrapment efficiency in a novel liposome-based formulation, LE-SN-38, J. Pharm. Biomed. Anal. 41 (2006) 582--588; DOI: 10.1016/j.jpba.2005.10.051.10.1016/j.jpba.2005.10.05116386867
- E. B. Denkbas, X. Kaitianm, A. Tuncel and E. Piskin, Rifampicin-carrying poly(D, L-lactide) microspheres: loading and release, J. Biomat. Sci-Polym. Ed. 6 (1995) 815--825; DOI: 10.1163/156856295X00201.10.1163/156856295X002017772568
- K. Yoncheva, E. Lizarraga and J. M. Irache, Pegylated nanoparticles based on poly(methyl vinyl ether-co-maleic anhydride): preparation and evaluation of their bioadhesive properties, Eur. J. Pharm. Sci. 24 (2005) 411--419; DOI: 10.1016/j.ejps.2004.12.002.10.1016/j.ejps.2004.12.002
- F. Esmaeili, M. H. Ghahremani, B. Esmaeili, M. R. Khoshayand, F. Atyabi and R. Dinarvand, PLGA nanoparticles of different surface properties: Preparation and evaluation of their body distribution, Int. J. Pharm. 349 (2008) 249--55; DOI: 10.1016/j.ijpharm.2007.07.038.10.1016/j.ijpharm.2007.07.038
- J. M. Harris, N. E. Martin and M. Modi, Pegylation: A novel process for modifying pharmacokinetics, Clin. Pharmacokinet. 40 (2001) 539--551.
- L. Mu and S. S. Feng, Vitamin E TPGS used as emulsi.er in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxols), J. Control. Rel. 80 (2002) 129--144; DOI: 10.1016/S0168-3659(02)00025-1.10.1016/S0168-3659(02)00025-1
- C. Dubernet, Thermoanalysis of microspheres, Thermochim. Acta 248 (1995) 259--269; DOI; 10.1016/0040-6031(94)01947-F.10.1016/0040-6031(94)01947-F
- B. Magenheim, M. Y. Levy and S. Benita, A new in vitro technique for evaluation of drug release profile from colloidal carriers-ultrafiltration technique at low pressure, Int. J. Pharm. 94 (1993) 115--123; DOI: 10.1016/0378-5173(93)90015-8.10.1016/0378-5173(93)90015-8